WallStreetZenWallStreetZen

NASDAQ: VTGN
Vistagen Therapeutics Inc Stock Ownership - Who owns Vistagen Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vistagen Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cynthia Lynn AndersonCHIEF FINANCIAL OFFICER2024-12-312,592$2.51
$6.50kBuy
Joshua S. PrinceChief Operating Officer2024-12-313,310$2.51
$8.30kBuy
Reid G. AdlerCHF CORP DEVEL OFF GEN COUNS2024-06-284,854$2.96
$14.36kBuy
Cynthia Lynn AndersonCHIEF FINANCIAL OFFICER2024-06-283,592$2.96
$10.63kBuy
Joshua S. PrinceChief Operating Officer2024-06-282,671$2.96
$7.90kBuy
Shawn SinghCHIEF EXECUTIVE OFFICER2024-06-284,854$2.96
$14.36kBuy

1 of 1

VTGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTGN insiders and whales buy or sell their stock.

VTGN Shareholders

What type of owners hold Vistagen Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Venrock Healthcare Capital Partners II LP71.50%20,637,286$47.26MInsider
Holding Co Cato11.47%3,310,836$7.58MInsider
Tcg Crossover Management LLC9.27%2,676,580$6.13MInstitution
Stempoint Capital LP8.07%2,328,492$5.33MInstitution
Vanguard Group Inc7.00%2,020,351$4.63MInstitution
Nantahala Capital Management LLC6.87%1,981,980$4.54MInstitution
Commodore Capital LP5.46%1,575,000$3.61MInstitution
Platinum Long Term Growth VII LLC5.40%1,558,862$3.57MInsider
Sphera Funds Management Ltd2.80%808,550$1.85MInstitution
Commodore Capital LP2.77%799,244$1.83MInsider

1 of 3

VTGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTGN35.98%64.02%Net Buying
SKYE3.44%96.56%Net Selling
ANRO77.00%23.00%Net Buying
PYXS51.20%37.91%Net Buying
ANL0.05%0.00%
View Top Biotech Stocks

Vistagen Therapeutics Stock Ownership FAQ

Who owns Vistagen Therapeutics?

Vistagen Therapeutics (NASDAQ: VTGN) is owned by 53.78% institutional shareholders, 95.69% Vistagen Therapeutics insiders, and 0.00% retail investors. Venrock Healthcare Capital Partners II LP is the largest individual Vistagen Therapeutics shareholder, owning 20.64M shares representing 71.50% of the company. Venrock Healthcare Capital Partners II LP's Vistagen Therapeutics shares are currently valued at $48.29M.

If you're new to stock investing, here's how to buy Vistagen Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.